Homburger advised PHOENIX Pharma Switzerland on the transaction. CMS Switzerland advised Voigt Group. PHOENIX Pharma Switzerland, a subsidiary of the family-owned PHOENIX group, and Voigt Holding...
PHOENIX Pharma Switzerland’s Joint Venture with Voigt Group
DKSH’s Acquisition of Terra Firma
Homburger and Morgan Lewis advised DKSH in the transaction while Faegre Drinker represented Goldner Hawn. Niederer Kraft Frey advised Bank of America, acting as bookrunning mandated...
FNZ’s Acquisition of New Access
Homburger AG advised BlackFin Capital Partners. BlackFin Capital Partners, an independent private equity firm focused on investing in financial services companies, fintechs and insurtechs, announced that...
Dufry’s Strategic Combination With Autogrill
Homburger, Davis Polk and Chiomenti advised Dufry on the deal, while Lenz & Staehelin and BonelliErede assisted Edizione. Gianni & Origoni and PwC TLS advised Autogrill...
DKSH’s Acquisition of The Refarmed Group
Homburger has advised DKSH in this transaction, while Gelmetti Studio Legale Associato and Greco Vitali Associati assisted the sellers. DKSH Holding Ltd (SIX: DKSH) announced the...
Addex Therapeutics’ PIPE Transaction With Armistice Capital
Homburger advised Addex in this transaction. Allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has entered into a definitive agreement...
ArchiMed’s Acquisition of Stragen Pharma Group
Walder Wyss advised Stragen Pharma and its shareholders in the transaction. Homburger acted as Swiss legal counsel to ArchiMed. Private equity healthcare fund ArchiMed announced the...
Heubach And SK Capital’s Acquisition of Clariant Pigments Business
Lenz & Staehelin advised Heubach and SK Capital on this transaction. Homburger advised Clariant. Kirkland & Ellis advised SK Capital Partners on the deal. The Heubach...
PolyPeptide Group AG’s CHF 848 Million Initial Public Offering on SIX Swiss Exchange
Homburger acted as counsel to the underwriters, while Niederer Kraft Frey and Clifford Chance advised PolyPeptide Group. PolyPeptide Group AG, a global leader in peptide development and...
Dufry’s CHF 300 Million Senior Notes And €725 Million Senior Notes Offering
Homburger acted as counsel to Dufry, while Davis Polk advised Dufry One B.V. on the deal. Dufry One B.V. launched and successfully completed the issuance of CHF...
Dufry’s CHF 500 Million Convertible Bonds Offer And Incentivized Conversion Offer
Homburger acted as counsel to Dufry. Dufry One B.V. launched and successfully completed the issuance of CHF 500 m guaranteed senior convertible bonds due 2026 (the 2026...